{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T09:09:14Z","timestamp":1779008954628,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006380","name":"BOKU University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jviromet.2026.115380","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:42:13Z","timestamp":1771918933000},"page":"115380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cytokine-based rapid process control of live virus production: MCP-1 as a cross-family biomarker in Vero cells"],"prefix":"10.1016","volume":"343","author":[{"given":"Johanna","family":"Bacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana Barbero","family":"Calzado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Nebenf\u00fchr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Schlegl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8182-7728","authenticated-orcid":false,"given":"Alois","family":"Jungbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jviromet.2026.115380_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009480","article-title":"Time to revisit the endpoint dilution assay and to replace the TCID as a measure of a virus sample's infection concentration","volume":"17","author":"Cresta","year":"2021","journal-title":"Plos Comput. Biol."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115380_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010877","article-title":"Time to revisit the endpoint dilution assay and to replace the TCID as a measure of a virus sample's infection concentration (vol 17, e1009480, 2021)","volume":"19","author":"Cresta","year":"2023","journal-title":"Plos Comput. Biol."},{"key":"10.1016\/j.jviromet.2026.115380_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jbiotec.2024.01.016","article-title":"Cytokines as fast indicator of infectious virus titer during process development","volume":"383","author":"Bacher","year":"2024","journal-title":"J. Biotechnol."},{"issue":"2","key":"10.1016\/j.jviromet.2026.115380_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010616","article-title":"Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: results from an open label, non-randomized clinical trial","volume":"17","author":"Sandberg","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"19","key":"10.1016\/j.jviromet.2026.115380_bib5","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.vaccine.2019.03.030","article-title":"Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO(R) in healthy adults: a five year follow-up study","volume":"37","author":"Taucher","year":"2019","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.jviromet.2026.115380_bib6","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1016\/j.vaccine.2016.07.029","article-title":"Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO(R) in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study","volume":"34","author":"Cramer","year":"2016","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jviromet.2026.115380_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac127","article-title":"A randomized, placebo-controlled, blinded phase 1 study investigating a novel inactivated, Vero cell-culture derived Zika virus vaccine","volume":"31","author":"Wressnigg","year":"2024","journal-title":"J. Travel Med"},{"issue":"2","key":"10.1016\/j.jviromet.2026.115380_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taad156","article-title":"A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults","volume":"31","author":"Mcmahon","year":"2024","journal-title":"J. Travel Med"},{"key":"10.1016\/j.jviromet.2026.115380_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115380_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2026.115380_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114440","article-title":"Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector","volume":"301","author":"Gupta","year":"2022","journal-title":"J. Virol. Methods"},{"issue":"15","key":"10.1016\/j.jviromet.2026.115380_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158076","article-title":"J. High-Throughput Determination of Infectious Virus Titers by Kinetic Measurement of Infection-Induced Changes in Cell Morphology","volume":"25","author":"Hotter","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jviromet.2026.115380_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114318","article-title":"Automated, label-free TCID assay to determine the infectious titer of virus-based therapeutics","volume":"299","author":"Hochdorfer","year":"2022","journal-title":"J. Virol. Methods"},{"issue":"5","key":"10.1016\/j.jviromet.2026.115380_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.jviromet.2026.115380_bib15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006049","article-title":"Signaling in innate immunity and inflammation","volume":"4","author":"Newton","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jviromet.2026.115380_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway","volume":"10","author":"Khan","year":"2021","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.jviromet.2026.115380_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21893","article-title":"SARS-CoV-2 activates the TLR4\/MyD88 pathway in human macrophages: a possible correlation with strong pro-inflammatory responses in severe COVID-19","volume":"9","author":"Sahanic","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115380_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1099\/0022-1317-43-1-247","article-title":"Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production","volume":"43","author":"Emeny","year":"1979","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2026.115380_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107608","article-title":"Vero cell upstream bioprocess development for the production of viral vectors and vaccines","volume":"44","author":"Kiesslich","year":"2020","journal-title":"Biotechnol. Adv."},{"issue":"10","key":"10.1016\/j.jviromet.2026.115380_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/v10100521","article-title":"Interplay between cellular metabolism and cytokine responses during viral infection","volume":"10","author":"Zhang","year":"2018","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.jviromet.2026.115380_bib21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.vaccine.2022.01.004","article-title":"A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine","volume":"40","author":"Steppert","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115380_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","article-title":"On the calculation of TCID for quantitation of virus infectivity","volume":"36","author":"Lei","year":"2021","journal-title":"Virol. Sin."},{"issue":"203","key":"10.1016\/j.jviromet.2026.115380_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2307\/2279703","article-title":"Discrete frequency distributions arising from mixtures of several single probability values (vol 33, pg 390, 1938)","volume":"33","author":"Muench","year":"1938","journal-title":"J. Am. Stat. Assoc."},{"issue":"31","key":"10.1016\/j.jviromet.2026.115380_bib24","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1016\/S0264-410X(01)00208-0","article-title":"A purified inactivated Japanese encephalitis virus vaccine made in vero cells","volume":"19","author":"Srivastava","year":"2001","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.jviromet.2026.115380_bib25","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1016\/j.vaccine.2015.05.103","article-title":"Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO\u00ae","volume":"33","author":"Schlegl","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jviromet.2026.115380_bib26","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ymthe.2023.05.004","article-title":"A non-transmissible live attenuated SARS-CoV-2 vaccine","volume":"31","author":"Adler","year":"2023","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115380_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41541-021-00317-4","article-title":"Considerations for bioanalytical characterization and batch release of COVID-19 vaccines","volume":"6","author":"Sanyal","year":"2021","journal-title":"NPJ Vaccin."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115380_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41541-022-00470-4","article-title":"Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies","volume":"7","author":"Sanyal","year":"2022","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.jviromet.2026.115380_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-0716-3890-3_8","article-title":"Median tissue culture infectious dose 50 (TCID(50)) assay to determine infectivity of cytopathic viruses","volume":"2813","author":"Baid","year":"2024","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"10.1016\/j.jviromet.2026.115380_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02036-19","article-title":"Chikungunya virus evades antiviral CD8 T cell responses to establish persistent infection in joint-associated tissues","volume":"94","author":"Davenport","year":"2020","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115380_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.176537","article-title":"Chikungunya virus infection disrupts lymph node lymphatic endothelial cell composition and function via MARCO","volume":"9","author":"Lucas","year":"2024","journal-title":"Jci Insight"},{"key":"10.1016\/j.jviromet.2026.115380_bib32","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.3389\/fimmu.2018.02862","article-title":"Cytokine-mediated tissue injury in non-human primate models of viral infections","volume":"9","author":"Manickam","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.jviromet.2026.115380_bib33","article-title":"Guidance for industry PAT \u2014 a framework for innovative pharmaceutical development, manufacturing, and quality assurance","author":"(FDA) USDoHaHSFaDA","year":"2004","journal-title":"Pharm. CGMPs"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093426000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093426000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:29:21Z","timestamp":1779006561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093426000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S0166093426000443"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115380","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine-based rapid process control of live virus production: MCP-1 as a cross-family biomarker in Vero cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115380"}}